NasdaqGM - Nasdaq Real Time Price USD
Vanda Pharmaceuticals Inc. (VNDA)
4.3400
+0.0100
+(0.23%)
As of 9:50:20 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,022,000 | 13 |
| Sales | 5,000 | 1 |
| Net Shares Purchased (Sold) | 1,017,000 | 14 |
| Total Insider Shares Held | 2.73M | -- |
| % Net Shares Purchased (Sold) | 59.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 5.01 - 5.02 per share. | Direct | 50,150 | Mar 6, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 5.01 - 5.03 per share. | Direct | 50,200 | Mar 5, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.70 per share. | Direct | 47,050 | Mar 3, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.76 per share. | Direct | 47,600 | Feb 28, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.76 per share. | Direct | 47,600 | Feb 27, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.75 - 4.78 per share. | Direct | 47,650 | Feb 26, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.46 per share. | Direct | 44,640 | Feb 25, 2025 |
| MORAN KEVIN PATRICK Chief Financial Officer | Purchase at price 4.39 per share. | Direct | 8,779 | Feb 21, 2025 |
| WILLIAMS TIMOTHY IAN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| WIJKSTROM JOAKIM PER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| MORAN KEVIN PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| BIRZNIEKS GUNTHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| MITCHELL STEPHEN RAY Director | Sale at price 5.17 per share. | Direct | 25,863 | Nov 14, 2024 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 5.92 per share. | Direct | 13,327 | Jul 29, 2024 |
| CHROUSOS PHAEDRA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2024 |
| WARD ANNE SEMPOWSKI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| MITCHELL STEPHEN RAY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| HONORE TAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| DUGAN RICHARD W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Sale at price 4.13 - 4.24 per share. | Direct | 231,339 | Mar 5, 2024 |
| BIRZNIEKS GUNTHER Officer | Sale at price 4.13 - 4.30 per share. | Direct | 73,379 | Mar 5, 2024 |
| WILLIAMS TIMOTHY IAN General Counsel | Sale at price 4.18 - 4.41 per share. | Direct | 73,313 | Mar 5, 2024 |
| WIJKSTROM JOAKIM PER Officer | Sale at price 4.21 - 4.41 per share. | Direct | 71,921 | Mar 5, 2024 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 4.20 - 4.48 per share. | Direct | 63,393 | Mar 5, 2024 |
| WILLIAMS TIMOTHY IAN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| WIJKSTROM JOAKIM PER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| MORAN KEVIN PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| BIRZNIEKS GUNTHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| WIJKSTROM JOAKIM PER Officer | Sale at price 5.84 per share. | Direct | 21,748 | Aug 21, 2023 |
| MITCHELL STEPHEN RAY Director | Sale at price 6.05 per share. | Direct | 39,349 | Aug 10, 2023 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 6.30 per share. | Direct | 13,945 | Jul 28, 2023 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 6.29 per share. | Direct | 100,710 | Jun 15, 2023 |
| WILLIAMS TIMOTHY IAN General Counsel | Sale at price 6.56 per share. | Direct | 95,754 | Jun 13, 2023 |
| CHROUSOS PHAEDRA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| WARD ANNE SEMPOWSKI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| MITCHELL STEPHEN RAY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| HONORE TAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| DUGAN RICHARD W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
Related Tickers
ACAD ACADIA Pharmaceuticals Inc.
14.55
-0.51%
CRVS Corvus Pharmaceuticals, Inc.
3.6504
+3.70%
SCPH scPharmaceuticals Inc.
2.5600
-1.54%
SWTX SpringWorks Therapeutics, Inc.
41.08
-0.32%
RIGL Rigel Pharmaceuticals, Inc.
18.26
+0.55%
LRMR Larimar Therapeutics, Inc.
2.2600
0.00%
VYGR Voyager Therapeutics, Inc.
3.5400
+1.43%
REPL Replimune Group, Inc.
8.90
+0.74%
VSTM Verastem, Inc.
7.38
+3.65%
CRDF Cardiff Oncology, Inc.
2.9400
0.00%